Shattering The Status Quo: How CSSi's AI-Powered Strategy Is Redefining Patient Recruitment Performance

For decades contract research organizations (CROs) and sponsors have wrestled with the same unsolved challenge: clinical trials that launch late, recruit slowly, and miss enrollment targets. CSSi, a veteran in patient recruitment, is breaking this cycle by fusing artificial intelligence with performance-based pricing—redefining what success in recruitment looks like. Through its collaboration with HumanTrue, CSSi has embedded the CLARA AI platform into its operations, enabling capabilities once thought impossible. Certified screeners can now be built in minutes, study content can be instantly translated to patient-friendly language, and site-ready materials can be generated automatically for each protocol. Most importantly, CLARA can pre-match patients to trials at scale, blending AI precision with the human insight of CSSi’s Local Enrollment Specialists.

For CROs, this model transforms trial startup and execution. Instead of speculative budgets and long setup periods, sponsors pay only for measurable outcomes such as referrals, ICFs, or randomizations. Trials launch faster—often in half the industry average timeline—while multilingual, AI-enabled engagement ensures broader and more inclusive reach. By combining automation with human trust, CSSi offers CROs and sponsors a powerful new paradigm: enrollment strategies rooted in speed, scalability, and accountability. The result is not just accelerated trials, but an accelerated industry.